Federal Court reinstates decision that REMICADE new use patent is valid and infringed
By EsqSocial Corporation 24/02/21
As reported previously... the Federal Court had found that Kennedy’s patent for infliximab (Janssen’s REMICADE) was valid and infringed by Hospira’s biosimilar INFLECTRA (“Trial Decision”). As reported... the Federal Court of Appeal remitted issues of anticipation and obviousness for reconsideration to the trial judge....
By: Smart & Biggar